Aetiology of, and risk factors for, recurrent community-acquired pneumonia

Clinical Microbiology and Infection

Volumn 15, Issue 11, 2009, Pages 1033-1038

  Garcia Vidal, C ^a   Carratala J ^a   Fernandez Sabe N ^a   Dorca, J ^b   Verdaguer, R ^c   Manresa, F ^b   Gudiol, F ^a  

^a Infectious Diseases Department   (Spain)

^b Deparment of Respiratory Medicine   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Community acquired pneumonia; Pneumococcal pneumonia; Pneumococcal vaccination; Recurrence

Indexed keywords

BACTERIAL ANTIGEN; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DISEASE PREDISPOSITION; FEMALE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BACILLI (CLASS); HAEMOPHILUS INFLUENZAE; LEGIONELLA PNEUMOPHILA; NEGIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 70449084888     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02918.x     Document Type: Article

References (29)

1. Garau J, Calbo E. Community-acquired pneumonia. Lancet 2008, 371:455-458.
2. Mandell LA, Wunderink RG, Anzueto A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(suppl 2):S27-72.
3. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998, 20:820-837.
4. Winterbauer RH, Bedon GA, Ball WC. Recurrent pneumonia. Predisposing illness and clinical patterns in 158 patients. Ann Intern Med 1969, 70:689-700.
5. Ekdahl K, Braconier JH, Rollof J. Recurrent pneumonia: a review of 90 adult patients. Scand J Infect Dis 1992, 24:71-76.
6. Hedlund J, Kalin M, Örtqvist A. Recurrence of pneumonia in middle-aged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions. Scand J Infect Dis 1997, 29:387-392.
7. Almirall J, Bolíbar I, Balanzó X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 1999, 13:349-355.
8. Hirai S, Hamanaka Y, Mitsui N, Uegami S, Matsuura Y. Surgical treatment of infected intralobar pulmonary sequestration: a collective review of patients older than 50 years reported in the literature. Ann Thorac Cardiovasc Surg 2007, 13:331-334.
9. Robbins J, Gensler G, Hind J. Comparison of 2 interventions for liquid aspiration on pneumonia incidence. A randomized trial. Ann Intern Med 2008, 148:509-518.
10. Ekdahl K, Braconier JH, Svanborg C. Immunoglobulin deficiencies and impaired immune response to polysaccharide antigens in adult patients with recurrent community-acquired pneumonia. Scand J Infect Dis 1997, 29:401-407.
11. Rosón B, Carratalà J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000, 31:869-874.
12. Carratalà J, Fernández-Sabé N, Ortega L. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med 2005, 142:165-172.
13. Férnandez-Sabé N, Carratalà J, Rosón B. Community-acquired pneumonia in very elderly patients. Causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 2003, 82:159-169.
14. Mykietiuk A, Carratalà J, Fernández-Sabé N. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis 2005, 40:794-799.
15. Mykietiuk A, Carratalà J, Domínguez A. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2006, 25:457-462.
16. Gilks CF, Ojoo SA, Ojoo JC. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996, 347:718-723.
17. Torres A, Dorca J, Zalacaín R. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med 1996, 154:1456-1461.
18. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006, 28:346-351.
19. Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med 2007, 101:2139-2144.
20. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001, 344:665-671.
21. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997, 8:1-24. Centers for Disease Control, Prevention
22. Ament A, Baltussen R, Duru G. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin Infect Dis 2000, 31:444-450.
23. Greci LS, Katz DL, Jekel J. Vaccinations in pneumonia: pneumococcal and influenza vaccination patterns among patients hospitalized for pneumonia. Prev Med 2005, 40:384-388.
24. Musher DM, Alexandraki I, Graviss EA. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000, 79:210-221.
25. Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients-12 western states, 1995. MMWR Morb Mortal Wkly Rep 1997, 46:919-923. Centers for Disease Control, Prevention
26. Plets MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008, 32:199-206.
27. Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006, 42:1093-1101.
28. Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 2007, 167:1938-1943.
29. Roy S, Knox K, Segal S. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 2002, 359:1569-1573.